This is the treatment most often used for non-Hodgkin’s lymphoma. And since chemotherapy may lower certain types of blood cells, a transfusion of a type of drug called blood cell growth factors may be needed. Liposomal drug delivery is an advanced way of giving chemotherapy that may help it be more effective.
Radiation therapy may be used in early-stage lymphoma or to help symptoms such as pain. It is seldom the only treatment given.
Immunotherapy for Non-Hodgkin’s lymphoma may include:
- Monoclonal antibodies, including Rituxan®
- Biological therapies that develop antibodies to help the body fight the cancer
- Proteasome inhibitors, such as Velcade®
- Immune modulators, such as thalidomide and lenalidomide, that modify the environment of the tumor cell and allow it to die
- Targeted therapies that attack cancer cells by using small molecules to block pathways cells used to survive and multiply
- Small molecule treatments such as panobinostat
- Cytokine therapies
- Interferon is made by the body to help fight infection. Sometimes interferon that has been made in the laboratory is given to patients with non-Hodgkin’s lymphoma.
Radioimmunotherapy pairs a monoclonal antibody to a radioactive substance to target cancer cells.
If non-Hodgkin’s lymphoma does not respond to chemotherapy or if it returns, your doctor may recommend a stem cell transplant. Also, since chemotherapy often destroys healthy cells in the blood and bone marrow, patients who have certain types of chemotherapy may need stem cell transplants.
Learn more about Stem Cell Transplantation
This approach involves closely monitoring non-Hodgkin’s lymphoma without active treatment.
Since Banner MD Anderson is one of the nation’s leading research centers, we’re able to offer clinical trials (research studies) of new treatments for every type and stage of non-Hodgkin’s lymphoma, including recurrent and relapsed disease.
Learn about the clinical trials available for lymphoma